Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer

Fig. 3

a Expression of SNHG3 in SNHG3 knocked down KY-SE150 and Eca-9706. b m6A level in SNHG3 knock down KY-SE150 and Eca-9706. c miR-186-5p expression in SNHG3 knock down KY-SE150 and Eca-9706. d METTL3 expression in SNHG3 knock down KY-SE150 and Eca-9706. e Expression of miR-186-5p in miR-186-5p overexpressed KY-SE150 and Eca-9706. f m6A level in miR-186-5p overexpressed KY-SE150 and Eca-9706. g METTL3 expression in miR-186-5p overexpressed KY-SE150 and Eca-9706. h SNHG3 expression in miR-186-5p overexpressed KY-SE150 and Eca-9706. i Rescue experiments for the effect of platinum treatment and SNHG3 knock down on m6A level. j Rescue experiments for the effect of platinum treatment and miR-186-5p overexpression on m6A level. k Rescue experiments for the effect of platinum treatment and METTL3 knock down on m6A level

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us